Navigation Links
Microparts interest group workshop
Date:8/7/2009

Recent advances in modern manufacturing techniques has made it possible to manufacture small and complex components to extremely high accuracies. In direct response to the extreme demands of quality assurance for the measurement of size, form and position of microsystem parts, extensive research is being carried out in the area of geometrical measurement on the micro-scale.

'Microparts' is a joint EURAMET research project in the area of micro co-ordinate metrology for miniature components. VSL, NPL, PTB and METAS are collaborating on the project in all aspects of micro CMM technology including the development of novel contact, optical and XCT probing techniques, machine calibration, stability, traceability and calibration artefacts. The workshop aims to disseminate the work of the project to the wider audience and discuss related research and development topics.

Topics include:

  • Updates on the development of novel micro-CMM probes
  • Development of micro-CMM platforms
  • Calibration and traceability of micro-CMM platforms
  • Integrated micro metrology and micro manufacturing techniques

A workshop dinner will be held on the evening of the 28th October


'/>"/>

Contact: Joe Meaney
joe@proofcommunication.com
44-845-680-1864
National Physical Laboratory
Source:Eurekalert

Page: 1

Related biology technology :

1. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
2. Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again
3. Xspray Expands to Meet Pharmas Interest in its Ground-Breaking Particle Production Technology
4. Managing Conflict of Interest Disclosures Simplified for Healthcare Organizations
5. China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
6. deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes
7. CTI Receives the Second Payment of $6.5 million Associated with the Sale of Interest in Zevalin Joint Venture
8. China Biologic Products Completes Acquisition of 35% Interest in Xian Huitian Blood Products Co., Ltd.
9. Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million
10. Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
11. Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
Breaking Biology News(10 mins):